Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 808 results for "daiichi sankyo company"

Daiichi Sankyo launches methemoglobinemia drug in Japan

Daiichi Sankyo Company, Limited, a Japanese pharmaceutical company, has launched Methylene Blue injection 50mg, indicated for the treatment of methemoglobinemia. Methylene Blue is one of the agents publicly offered for development by the Review ..., 5 days ago
Daiichi Sankyo eyes valuation gain in Ranbaxy deal Nikkei Asian Review, 5 days ago
Bio Spectrum Asia

AstraZeneca and Daiichi Sankyo to Jointly Commercialize Movantik in the U.S.

/PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR ) reported that partner AstraZeneca today announced a co-commercialisation agreement with Daiichi Sankyo, Inc. for MOVANTIK (naloxegol) in the US, in line with the Company's strategy of delivering ...
 Pharmaceutical & Medical Packaging News1 week ago ViewPoints: AstraZeneca steps up externalisation strategy with Daiichi-Sankyo/Movantik deal  FirstWord Pharma1 week ago AstraZeneca to commercialize Daiichi Sankyo's OIC drug  Bio Spectrum Asia1 week ago AstraZeneca, Daiichi Sankyo Ink Co-Commercialization Deal  Nordic Life Science1 week ago

DAIICHI SANKYO : N.C. to get share of $39 million in doctor kickback case

March 25 -- RALEIGH -- Drug maker Daiichi Sankyo will pay more than $39 million in a settlement regarding alleged kickbacks to get doctors to prescribe the company's drugs, according to a news release from N.C. Attorney General Roy Cooper . The ...
 4 Traders5 days ago Georgia Enters National Settlement with Pharmaceutical Company Daiichi Sankyo to Resolve Kickback Allegations  Noodls1 week ago Press Release: A.G. SCHNEIDERMAN ANNOUNCES KICKBACK SETTLEMENT WITH PHARMA MANUFACTURER DAIICHI-SANKYO  iMarketReports2 weeks ago Daiichi Sankyo to pay $39 million to settle U.S. kickback claims: DOJ  Reuters2 months ago
Nikkei Asian Review

Announcement Regarding Closure of Merger Between Daiichi Sankyo Subsidiary Ranbaxy and Sun Pharma

25 Mar 15 Following its announcement of April 7, 2014, that Sun Pharmaceutical Industries Ltd. (Sun Pharma) was to acquire Ranbaxy Laboratories Limited (Ranbaxy) through a merger entailing an all-stock transaction, Daiichi Sankyo Company, Limited ...
 PharmiWeb6 days ago RIP Ranbaxy  Business Today India4 days ago Sun Pharma wraps up Ranbaxy deal  Nikkei Asian Review5 days ago Sun Pharmaceuticals completes buyout of Ranbaxy  Investor's Business Daily5 days ago

Daiichi Sankyo Tightens Belt and Kicks Off Cuts to Total 16%

March 24, 2015 By Mark Terry , Breaking News Staff Tokyo-based Daiichi Sankyo, Inc. , which has U.S. headquarters in Parsippany, N.J., announced today it will begin laying off 16 percent of its U.S. staff starting Monday March ...
 BioSpace6 days ago BRIEF-AstraZeneca announces collaboration with Japan's Daiichi Sankyo  Reuters UK1 week ago

AstraZeneca plc (ADR) And Daiicho Sankyo To Co-Market OIC Drug Movantik In The US

AstraZeneca plc (ADR) ( NYSE:AZN ) announced on Thursday an agreement with Daiichi Sankyo Co LT ( OTCMKTS:DSKYF ) to jointly market its constipation drug MOVANTIK in the US. MOVANTIK is a first-in-class mu receptor-targeting drug designed to ...
 Mr Top Step1 week ago AstraZeneca, Daiichi Sankyo to Co-Market Movantik in U.S. - Analyst Blog  Yahoo! Finance1 week ago

UPDATED: Daiichi Sankyo starts layoff drive with 16% cuts at HQ

Daiichi Sankyo's Parsippany, NJ, facility Times have been tough for Daiichi Sankyo, and they're about to get tougher for some of the Japanese company's U.S. staffers. The drugmaker is cutting its commercial headquarters staff by 16% on Monday, ...
 FiercePharma6 days ago Daiichi Sankyo starts layoff drive with 16% cuts at HQ  FierceMedicalDevices6 days ago

ASTRAZENECA : Teams With Daiichi Sankyo To Sell Movantik In US

LONDON ( Alliance News ) - AstraZeneca PLC Thursday said it will co-commercialise its Movantik treatment for opioid-induced constipation in adults with chronic non-cancer pain with Daiichi Sankyo Inc , in line with its recent strategy of developing ...
 4 Traders1 week ago AstraZeneca Teams With Daiichi Sankyo To Sell Movantik In US  London South East1 week ago
New York Business Journal

DAIICHI SANKYO : State to Receive $690,000 Under Settlement with New-Jersey-Based Drug Maker over Alleged Unlawful Incentives to Physicians

Acting Attorney General John J. Hoffman announced today that New Jersey will receive a total of $690,000 as a result of its participation in a global settlement with pharmaceutical manufacturer Daiichi Sankyo, Inc. , that resolves allegations the ...
 4 Traders1 week ago New York to get $2.4M in settlement with Daiichi Sankyo  New York Business Journal2 weeks ago

Cough Therapeutics Pipeline Review 2015 Featuring 34 Companies

Research and Markets ( has announced the addition of the "Cough - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic ...
 Individual.com5 days ago Research and Markets: Cough Therapeutics Pipeline Review 2015 Featuring 34 Companies  Green Technology5 days ago Coronary Artery Disease Partnering 2010-2015: Deals and agreements entered into by the world's leading healthcare companies  Individual.com1 week ago 2010-2015 Myocardial Infarction Partnering Deals and Agreements Deals Analysis for the World's Leading Healthcare Companies  Individual.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less